VCA Inc (WOOF) : Eqis Capital Management scooped up 3,731 additional shares in VCA Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 4, 2016. The investment management firm now holds a total of 16,272 shares of VCA Inc which is valued at $1,128,138.VCA Inc makes up approximately 0.07% of Eqis Capital Management’s portfolio.
Other Hedge Funds, Including , Washington Trust Bank added WOOF to its portfolio by purchasing 19 company shares during the most recent quarter which is valued at $1,317.
VCA Inc closed down -1.13 points or -1.62% at $68.69 with 6,45,583 shares getting traded on Tuesday. Post opening the session at $69.64, the shares hit an intraday low of $68.41 and an intraday high of $69.98 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, VCA Inc reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.82. The company had revenue of $653.49 million for the quarter, compared to analysts expectations of $637.18 million. The company’s revenue was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 EPS.
Many Wall Street Analysts have commented on VCA Inc. VCA Inc was Resumed by BofA/Merrill to “Buy” on Sep 29, 2016.
VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Company’s animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Company’s communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Company’s network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.